Journals / Glokom Katarakt / 2012 / Cilt: 7 - Sayı: 2

Blue-light filtering ıntraocular lenses

Mavi ışığı süzen göz içi mercekleri

Pages
132–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Studies showed that these IOLs have no negative effect on visual acuity, contrast sensitivity, color vision, scotopic vision, or circadian rhythm.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The life expectancy of elderly cataract patients is increasing and intraocular lens (IOL) implantation is performed in pediatric cataract patients who will have an even longer life expectancy.
📊
Key Findings & Data:Longer life expectancy has increased the implantation of blue-filtering IOLs, which are more protective against the harmful effects of light.
💡
Conclusion & Impact:Studies showed that these IOLs have no negative effect on visual acuity, contrast sensitivity, color vision, scotopic vision, or circadian rhythm.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The life expectancy of elderly cataract patients is increasing and intraocular lens (IOL) implantation is performed in pediatric cataract patients who will have an even longer life expectancy. Longer life expectancy has increased the implantation of blue-filtering IOLs, which are more protective against the harmful effects of light. Studies showed that these IOLs have no negative effect on visual acuity, contrast sensitivity, color vision, scotopic vision, or circadian rhythm.

Özet

Göz içi merceklerinin (GİL) yerleştirildiği yaşlı katarakt olgularının yaşam beklentisi uzamakta ve GİL'ler pediatrik katarakt gibi yaşam beklentisi daha da uzun olan olgularda kullanılmaktadır. Yaşam beklentisinin uzaması ışık hasarına karşı daha koruyucu olan mavi ışığı süzen lenslerin kullanılmasını artırmıştır. Yapılan çalışmalar bu lenslerin renkli görme, görme keskinliği, kontrast duyarlılık, skotopik görme ve günlük döngü üzerine olumsuz etkisi olmadığını göstermektedir.

🔖

Cite This Article

ÖNCEL, B., AKOVA, Y. (2012). Blue-light filtering ıntraocular lenses. Glokom Katarakt, Cilt: 7 - Sayı: 2, 132–136. https://ajindex.com/articles/226495

References (17)

  1. Mainster MA, Sparrow JR. How much blue light should an IOL transmit? Br J Ophthalmol 2003;87:1523-9
  2. Mainster MA. Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol 2005;123:550-5
  3. Mainster MA. Violet and blue light blocking intraocular lens es: photoprotection versus photoreception. Br J Ophthalmol 2006;90:784-92
  4. Ham WT Jr, Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature 1976;260:153-5
  5. Grimm C, Wenzel A, Williams T, et al. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci 2001;42:497-505
  6. Hafezi F, Marti A, Munz K, et al. Light-induced apoptosis: differential timing in the retina and pigment epithelium. Exp Eye Res 1997;64:963-70
  7. Van Norren D, van de Kraats J. Spectral transmission of in traocular lenses expressed as a virtual age. Br J Ophthalmol 2007;91:1374-5
  8. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthal mol 1992;110:1701-8
  9. Taylor HR, West S, Munoz B, et al. The long term effects of visible light on the eye.Arch Ophthalmol 1992;110:99-104
  10. Tomany SC, Cruickshanks KJ, Klein R, et al. Sunlight and the 10 year incidence of age related maculopathy: the Beaver Dam Eye Study.Arch Ophthalmol 2004;122:750-7
  11. Arnarsson A, Sverrisson T, Stefansson E, et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Am J Ophthalmol 2006;142:419-28
  12. Fletcher AE, Bentham GC, Agnew M, et al. Sunlight expo sure, antioxidants and age related macular deeneration. Arch Ophthalmol 2008;126:1396-403
  13. Darzins P, Mitchell P, Heller RF. Sun exposure and age relat ed macular degeneration. An Australian case-control study. Ophthalmology 1997;104:770-6
  14. Sutter FK, Menghini M, Barthelmes D, et al. Is pseudophakia a risk factor for neovaskular age-related macular degenera tion? Invest Ophthalmol Vis Sci 2007;48:1472-5
  15. Xu L, Li Y, Zheng Y, et al. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol 2006;90:1087-90
  16. Baatz H, Darawsha R, Ackermann H, et al. Phacoemulsifica tion does not induce neovascular age-related macular degen eration. Invest Ophthalmol Vis Sci 2008;49:1079-83
  17. Chew EY, Sperduto RD, Milton RC, et al. Risk of advanced age-related macular degeneration after cataract surgery in t